Diversity in Trials
21 videos · last 6 months shuffled daily, then older videos newest first
▶
11:21 Journey to Better Health: How to Effectively Engage the Public in Clinical Research
CISCRP's Community Engagement team on the Journey to Better Health mobile exhibit, which has taken clinical research to underserved communities across the United States since 2023.
▶
45:51 Country-Wide Barriers to Clinical Trial Access in Colorectal Cancer
Dr. Cecilia Monge, Medical Director in Clinical Development at Johnson & Johnson, explores barriers to colorectal cancer trial access in low- and middle-income nations, from research capacity to diverse enrollment, for the Global Colon Cancer Association.
▶
2:25 Breaking the "Last Resort" Myth of Clinical Research
Dr. Gregory Vidal, Director of Clinical Research at West Cancer Center, on why trials lack representation — starting with whether patients are asked to take part at all.
▶
44:40 Who Clinical Trials Left Out, and Why It Matters
Pediatrician Dr. Kerry Sease and health equity researcher Dr. Shaniece Criss discuss why women, children and people of color were often left out of clinical trials and how that gap still affects drug dosing and device accuracy, for FOX Carolina News.
▶
9:33 Racial and Ethnic Diversity in Parkinson's Drug Trials
Dr. Farley Reis Rodrigues and Dr. Daniel Di Luca present their systematic review of racial and ethnic diversity in trials of disease-modifying drugs for Parkinson's disease, for the International Parkinson and Movement Disorder Society.
▶
27:35 Yesenia Salinas on Running Trials at Research Sites
Yesenia Salinas, Founder and CEO of MedPoint Research Institute, discusses running trials at site level, including recruitment and retention, what sponsors and CROs misunderstand about site operations, and access for underserved communities, for mdgroup.
▶
56:46 Kidney Disease Clinical Trials: Lived Experiences
Grant Bonebrake, Lisa Bonebrake, Jill Goodrich and Curtis Warfield discuss the experiences of patients, caregivers and advocates in kidney disease clinical trials, barriers that limit diversity, and supports participants may encounter, for kidneyfund.
▶
1:29:51 Enhancing Diversity in Clinical Trials: Implementation of Diversity Plans
A Friends of Cancer Research meeting on putting diversity plans into practice, with a keynote from FDA Principal Deputy Commissioner Namandjé Bumpus and sessions on enrolment targets and more inclusive trials.
▶
1:01:49 Industry Panel Insights on FDA's Guidance and Inclusive Clinical Trials
Industry experts at the Stanford Think Tank on Diversity and Health Equity in Clinical Trials discuss the FDA's guidance on inclusive trials.
▶
53:45 What to Know About FDA Diversity Action Plans
Fortrea explains FDA guidance on Diversity Action Plans, its key changes and what it means for how sponsors plan and run clinical trials, with case studies.
▶
6:15 Native American and Indigenous Participation in Clinical Trials
Lung cancer is a leading cause of death from cancer among Native Americans, and this video looks at the importance of Native American representation in clinical trials along with disparities affecting Native Americans with lung cancer.
▶
1:25 Walgreens Building the Future of Clinical Trials
Walgreens wants to expand access to clinical trials beyond the 5% of the US population who participates in clinical trials, 75% of whom are Caucasian and has 9000 stores across the US to bring trials to a more diverse patient population using their Pharmacy care teams.
▶
59:33 Decentralized Studies for Cancer Screening Diagnostics
Elligo Health Research speakers discuss hybrid and decentralized strategies for clinical performance studies of liquid biopsy cancer screening diagnostics, including recruitment, specimen logistics and data integrity.
▶
9:59 Clinical Data in Successful IVD Regulatory Submissions
Margot Borgel, Director of IVD Global Regulatory Affairs at RQM+, and Nancy Morrison discuss when IVD submissions need clinical data, FDA and EU expectations, study design, patient selection and the IVDR transition.
▶
2:24 Reaching Diverse Patients Using Social Media
Eli Lilly developed a mobile lab to bring trials to increase diversity and most people now learn about trials through social media in this video looking at diversity and how the lab is now being used to bring decentralized clinical trials to underrepresented populations.
▶
4:33 All Creatures Great And Small, Except Women
Women have been historically underrepresented in Clinical Trials as shown in this video from HBO’s Wyatt Cenac.
▶
2:30 Ingrid Oakley-Girvan, SVP of Research and Strategy at Medable Discusses Way to Reach Patients
Ingrid Oakley-Girvan, SVP of Research and Strategy at Medable discusses how to reach unrepresented populations including use of the pharmacist as a starting point for engaging patients in clinical trials.
▶
22:10 CVS Panel on Clinical Trials and Diversity
A team from CVS and Moderna look at diversity in clinical trials along with a discussion of decentralized clinical trials and a study in women testing a vaccine for cytomegalovirus in this video on CVS' "innovative new approach."
▶
1:03:52 Diversity and Health Equity in Clinical Trials: Expert Panel
Andra Blomkalns, MD, Ruth O'Hara, PhD, Harriet Van Spall, MD, MPH, and Keith Norris, MD, discuss how the FDA and organisations could promote diversity and health equity in clinical trials, at a Stanford think tank.
▶
4:53 Alzheimer's Grant Leads to New Clinical Trials
Sid O'Bryant, Ph.D , from the The University of North Texas Health Science Center, discusses a $150 million grant that will be used to fund the "single most comprehensive study" of Alzheimer's disease among the 3 largest racial/ethnic groups in the United States.
▶
4:06 Telenovelas Raise Awareness of Alzheimer's Disease and Clinical Trials
Telenovelas Raise Awareness of Alzheimer's Disease and Clinical Trials in the Latino community in this video from local Houston news.